Ticker: LYEL

Company: Lyell Immunopharma, Inc.

Person: OTIS W BRAWLEY, director

Transaction date: March 31, 2025

Reporting date: April 2, 2025

Average share price: 0.56

Bought 35640.0 shares for 19958.4